Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
NCT07219927
This study is recruiting at 5 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
Real-World Participants Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: A Prospective, Phase 4, Multicenter, Observational Study in Parkinson's Disease
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Parkinson Disease
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Last updated on ClinicalTrials.gov
- October 22, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 3
- Parkinson's Disease and Movement Disorders Center - Orange County (South) · Aliso Viejo, CA
- Parkinson's Disease and Movement Disorders Center - Orange County (North) · Irvine, CA
- Parkinson's Research Centers of America - Palo Alto · Palo Alto, CA
Florida · 1
- Parkinson's Disease & Movement Disorders Center of Boca Raton · Boca Raton, FL
New York · 1
- Parkinson's Disease and Movement Disorders Center - Long Island · Commack, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.